Cargando…
Proteasome inhibition blocks necroptosis by attenuating death complex aggregation
Proteasome inhibitors have achieved clinical success because they trigger intrinsic and extrinsic cell death to eliminate susceptible human cancers. The ubiquitin-proteasome protein degradation system regulates signaling pathways by controlling levels of components such as cellular inhibitor of apop...
Autores principales: | Ali, Mohammad, Mocarski, Edward S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832869/ https://www.ncbi.nlm.nih.gov/pubmed/29497034 http://dx.doi.org/10.1038/s41419-018-0371-x |
Ejemplares similares
-
Autophagy complexes cell death by necroptosis
por: Goodall, Megan L., et al.
Publicado: (2016) -
Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes
por: Ayyadevara, Srinivas, et al.
Publicado: (2015) -
Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis
por: Bolik, Julia, et al.
Publicado: (2021) -
Spatial Organization of Proteasome Aggregates in the Regulation of Proteasome Homeostasis
por: Karmon, Ofri, et al.
Publicado: (2020) -
Filamentous Aggregates Are Fragmented by the Proteasome Holoenzyme
por: Cliffe, Rachel, et al.
Publicado: (2019)